精华制药 - Financials

精华制药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
+Revenue	1.4B	1.5B	1.6B	1.4B	1.3B	1.2B	1.4B	1.1B	881.0M	780.0M	578.0M	733.0M	665.0M	376.0M	274.0M	259.0M	235.0M	230.0M	210.0M
Revenue Growth %	-7.3%	-3.9%	15.8%	6.0%	10.7%	-14.6%	20.9%	27.2%	12.9%	34.9%	-21.1%	10.2%	76.9%	37.2%	5.8%	10.2%	2.2%	9.5%	--
Total Revenue	1.4B	1.5B	1.6B	1.4B	1.3B	1.2B	1.4B	1.1B	881.0M	780.0M	578.0M	733.0M	665.0M	376.0M	274.0M	259.0M	235.0M	230.0M	210.0M
Cost Of Revenue	706.0M	776.0M	838.0M	726.0M	662.0M	631.0M	704.0M	562.0M	444.0M	480.0M	354.0M	522.0M	471.0M	230.0M	133.0M	133.0M	129.0M	130.0M	127.0M
+Gross Profit	696.0M	736.0M	735.0M	632.0M	619.0M	526.0M	651.0M	559.0M	437.0M	300.0M	224.0M	211.0M	194.0M	146.0M	141.0M	126.0M	106.0M	100.0M	83.0M
Gross Margin %	49.6%	48.7%	46.7%	46.5%	48.3%	45.5%	48.0%	49.9%	49.6%	38.5%	38.8%	28.8%	29.2%	38.8%	51.5%	48.6%	45.1%	43.5%	39.5%
Total Operating Cost	1.1B	1.2B	1.4B	1.2B	1.2B	1.7B	1.1B	958.0M	695.0M	693.0M	545.0M	693.0M	621.0M	337.0M	225.0M	220.0M	203.0M	196.0M	192.0M
Selling Expenses	248.0M	228.0M	252.0M	215.0M	177.0M	175.0M	169.0M	141.0M	116.0M	105.0M	89.5M	79.3M	72.6M	57.5M	50.9M	49.8M	37.0M	30.1M	27.1M
Admin Expenses	119.0M	119.0M	149.0M	138.0M	125.0M	119.0M	116.0M	93.9M	136.0M	102.0M	82.0M	74.3M	71.5M	44.2M	37.1M	32.7M	30.5M	30.6M	29.5M
Rd Expenses	61.8M	64.6M	87.0M	74.8M	52.1M	82.8M	40.3M	37.7M	--	--	--	--	--	--	--	--	--	--	--
Finance Expenses	-44.7M	-23.1M	-15.0M	548,700	16.7M	21.9M	3.1M	2.5M	-10.8M	-11.0M	7.0M	4.7M	-1.7M	-2.5M	385,300	1.1M	3.5M	3.4M	4.9M
+Operating Income	295.0M	331.0M	251.0M	181.0M	63.3M	-498.0M	293.0M	171.0M	194.0M	93.0M	39.8M	39.2M	43.9M	38.5M	48.9M	39.5M	31.6M	33.1M	18.0M
Operating Margin %	21.0%	21.9%	16.0%	13.3%	4.9%	-43.0%	21.6%	15.3%	22.0%	11.9%	6.9%	5.4%	6.6%	10.2%	17.9%	15.3%	13.4%	14.4%	8.6%
Non Operating Income	3.2M	1.1M	1.8M	258,900	3.2M	1.1M	2.3M	48.9M	10.2M	4.5M	12.8M	14.4M	29.0M	19.0M	1.8M	210,300	693,000	6.8M	215,200
Non Operating Expenses	4.9M	2.2M	3.1M	1.9M	2.7M	3.6M	7.3M	2.9M	1.9M	724,100	1.5M	10.8M	833,000	351,800	515,600	661,300	428,500	990,200	923,700
Investment Income	4.4M	238,400	24.5M	-666,300	13.9M	9.7M	5.7M	1.2M	7.0M	5.6M	7.0M	--	--	--	--	--	--	-275,300	162,600
Fair Value Change Income	3.8M	6.8M	5.0M	32.1M	-3.5M	21.6M	--	--	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-202,300	-87,100	-59,300	-579,400	3.3M	7.1M	-1.3M	122,900	--	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	15.3M	7.9M	23.2M	28.6M	186.0M	501.0M	26.6M	102.0M	175,000	12.0M	7.8M	6.8M	4.3M	4.3M	683,400	-263,600	1.3M	100,700	980,800
Other Income	13.8M	7.3M	10.7M	7.6M	7.6M	4.7M	13.7M	6.6M	--	--	--	--	--	--	--	--	--	--	--
Income Before Tax	293.0M	330.0M	250.0M	179.0M	63.7M	-501.0M	288.0M	217.0M	202.0M	96.7M	51.1M	42.8M	72.1M	57.2M	50.2M	39.1M	31.9M	38.9M	17.3M
Income Tax	45.9M	53.2M	37.9M	38.9M	35.8M	23.7M	28.4M	26.5M	28.5M	14.9M	10.5M	2.2M	12.5M	8.8M	7.5M	6.3M	5.7M	13.3M	5.5M
+Net Income	247.0M	276.0M	212.0M	140.0M	27.9M	-524.0M	260.0M	190.0M	173.0M	81.8M	40.6M	40.7M	59.6M	48.4M	42.6M	32.8M	26.2M	25.6M	11.8M
Net Margin %	17.6%	18.3%	13.5%	10.3%	2.2%	-45.3%	19.2%	16.9%	19.6%	10.5%	7.0%	5.5%	9.0%	12.9%	15.6%	12.7%	11.1%	11.1%	5.6%
Net Income Attributable	213.0M	248.0M	212.0M	161.0M	111.0M	-394.0M	230.0M	175.0M	165.0M	78.1M	39.5M	35.6M	49.2M	48.1M	42.6M	32.8M	26.2M	25.6M	11.8M
Minority Interest	34.8M	28.8M	64,000	-20.7M	-83.1M	-131.0M	30.4M	15.0M	8.4M	3.8M	1.2M	5.1M	10.4M	249,600	8.00	46.00	100.00	-200.00	--
Eps Basic	0.26	0.30	0.26	0.20	0.14	-0.48	0.28	0.21	0.20	0.20	0.20	0.18	0.25	0.24	0.44	0.55	0.44	0.43	0.20
Eps Diluted	0.26	0.30	0.26	0.20	0.14	-0.48	0.28	0.21	0.20	0.20	0.20	0.18	0.25	0.24	0.44	0.55	--	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
Cash And Equivalents	1.0B	922.0M	933.0M	652.0M	581.0M	300.0M	211.0M	388.0M	386.0M	485.0M	866.0M	136.0M	202.0M	366.0M	402.0M	57.1M	24.7M	22.9M	9.9M
Trading Financial Assets	105.0M	318.0M	125.0M	213.0M	115.0M	36.3M	--	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	291.0M	249.0M	219.0M	214.0M	235.0M	275.0M	455.0M	294.0M	140.0M	292.0M	135.0M	178.0M	135.0M	103.0M	31.8M	30.6M	27.1M	28.7M	28.1M
Notes Receivable	44.0M	49.9M	22.8M	29.2M	30.2M	36.8M	39.7M	43.3M	21.5M	9.1M	4.2M	17.9M	13.3M	2.0M	--	--	--	969,700	355,300
Notes And Accounts Receivable	335.0M	299.0M	242.0M	243.0M	266.0M	312.0M	495.0M	338.0M	162.0M	301.0M	139.0M	196.0M	149.0M	105.0M	31.8M	30.6M	27.1M	29.6M	28.5M
Prepayments	6.7M	22.6M	20.4M	29.4M	13.6M	15.6M	18.2M	12.1M	10.7M	18.2M	12.0M	19.8M	4.5M	44.8M	28.4M	2.2M	483,600	425,600	1.3M
Inventory	270.0M	291.0M	308.0M	323.0M	308.0M	346.0M	445.0M	416.0M	293.0M	222.0M	185.0M	153.0M	102.0M	74.4M	50.6M	33.2M	41.2M	38.7M	34.5M
Total Current Assets	1.8B	2.0B	1.7B	1.6B	1.4B	1.1B	1.2B	1.3B	873.0M	1.0B	1.2B	522.0M	460.0M	594.0M	513.0M	124.0M	96.7M	92.3M	75.9M
Long Term Equity Investment	--	38.9M	40.1M	--	77.5M	78.3M	68.4M	67.9M	66.4M	59.4M	--	--	--	--	--	--	--	--	5.3M
Fixed Assets	--	592.0M	645.0M	1.1B	937.0M	772.0M	748.0M	630.0M	502.0M	489.0M	390.0M	356.0M	195.0M	103.0M	77.6M	80.4M	87.6M	95.3M	103.0M
Fixed Assets Total	562.0M	592.0M	645.0M	1.1B	937.0M	772.0M	748.0M	630.0M	502.0M	489.0M	390.0M	356.0M	195.0M	103.0M	77.6M	80.4M	87.6M	95.3M	103.0M
Construction In Progress	--	69.4M	61.5M	59.4M	274.0M	501.0M	474.0M	413.0M	211.0M	63.1M	89.3M	46.0M	148.0M	52.5M	8.2M	3.7M	104,000	670,400	1.2M
Construction In Progress Total	53.6M	69.4M	61.5M	59.4M	274.0M	501.0M	474.0M	413.0M	211.0M	63.1M	89.3M	46.0M	154.0M	52.5M	8.2M	3.7M	104,000	670,400	1.2M
Intangible Assets	60.5M	62.5M	65.1M	123.0M	123.0M	155.0M	170.0M	145.0M	150.0M	138.0M	122.0M	99.5M	102.0M	11.4M	9.7M	10.2M	10.6M	10.3M	10.5M
Long Term Deferred Expenses	--	--	--	14.0M	11.0M	13.1M	13.3M	803,000	997,100	--	--	--	--	--	--	--	--	--	--
Total Non Current Assets	1.5B	1.2B	1.3B	1.6B	1.7B	1.8B	2.2B	2.0B	1.7B	1.5B	669.0M	549.0M	498.0M	187.0M	98.4M	96.5M	99.2M	108.0M	122.0M
Total Assets	3.3B	3.2B	3.0B	3.2B	3.2B	2.9B	3.4B	3.2B	2.5B	2.5B	1.9B	1.1B	958.0M	781.0M	611.0M	220.0M	196.0M	200.0M	198.0M
Short Term Borrowings	10.4M	20.9M	21.0M	68.8M	76.6M	210.0M	174.0M	50.0M	20.0M	108.0M	118.0M	75.0M	17.8M	--	--	25.0M	30.0M	40.0M	60.7M
Accounts Payable	142.0M	128.0M	123.0M	178.0M	168.0M	110.0M	120.0M	161.0M	57.5M	55.7M	75.6M	127.0M	93.5M	78.5M	29.6M	28.3M	26.2M	25.8M	24.2M
Advance Receipts	--	--	--	--	--	11.3M	12.0M	9.1M	10.9M	8.5M	5.4M	4.8M	4.2M	3.4M	1.4M	2.8M	1.9M	2.4M	2.9M
Contract Liabilities	11.4M	13.6M	45.1M	30.4M	16.3M	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	326.0M	362.0M	395.0M	603.0M	528.0M	554.0M	505.0M	338.0M	218.0M	261.0M	274.0M	258.0M	172.0M	118.0M	58.4M	79.6M	73.2M	103.0M	116.0M
Long Term Borrowings	--	--	--	--	120.0M	220.0M	180.0M	240.0M	--	--	--	--	--	--	--	--	--	--	330,000
Total Non Current Liabilities	19.1M	19.2M	23.6M	25.3M	141.0M	239.0M	201.0M	256.0M	10.4M	11.2M	78.2M	71.2M	70.9M	25.9M	8.6M	3.6M	4.1M	5.1M	12.1M
Total Liabilities	345.0M	381.0M	418.0M	629.0M	669.0M	794.0M	705.0M	594.0M	228.0M	272.0M	352.0M	329.0M	243.0M	144.0M	67.0M	83.3M	77.3M	108.0M	128.0M
Paid In Capital	814.0M	814.0M	814.0M	836.0M	836.0M	836.0M	836.0M	841.0M	420.0M	280.0M	260.0M	200.0M	200.0M	100.0M	80.0M	60.0M	60.0M	60.0M	60.0M
Capital Reserve	769.0M	769.0M	906.0M	1.0B	1.0B	868.0M	868.0M	912.0M	1.3B	1.5B	897.0M	274.0M	255.0M	355.0M	375.0M	22.7M	22.7M	22.7M	591,100
Surplus Reserve	130.0M	118.0M	101.0M	87.9M	72.7M	65.4M	65.4M	47.6M	39.9M	31.3M	26.9M	24.0M	19.3M	15.7M	11.0M	6.7M	3.4M	826,600	3.8M
Retained Earnings	865.0M	743.0M	577.0M	427.0M	315.0M	211.0M	645.0M	475.0M	370.0M	242.0M	194.0M	168.0M	147.0M	111.0M	75.7M	45.3M	30.8M	7.2M	5.6M
Minority Equity	374.0M	360.0M	223.0M	334.0M	379.0M	298.0M	412.0M	366.0M	154.0M	198.0M	151.0M	72.0M	90.4M	51.2M	9,800	9,800	9,700	9,600	--
Equity Attributable	2.6B	2.4B	2.4B	2.2B	2.1B	1.9B	2.3B	2.3B	2.1B	2.0B	1.4B	670.0M	624.0M	585.0M	544.0M	137.0M	119.0M	91.8M	70.0M
Total Equity	3.0B	2.8B	2.6B	2.6B	2.5B	2.1B	2.7B	2.6B	2.3B	2.2B	1.5B	742.0M	715.0M	636.0M	544.0M	137.0M	119.0M	91.9M	70.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006
Cash From Sales	1.4B	1.5B	1.6B	1.4B	1.2B	1.2B	1.1B	982.0M	1.0B	612.0M	583.0M	642.0M	618.0M	309.0M	279.0M	270.0M	239.0M	231.0M	221.0M
Tax Refunds Received	211,300	887,000	2.0M	7.3M	15.0M	7.0M	22.8M	6.7M	4.5M	7.1M	7.1M	4.1M	3.4M	--	--	1.7M	--	228,900	--
Total Operating Cash Inflow	1.5B	1.5B	1.7B	1.5B	1.3B	1.3B	1.1B	1.0B	1.1B	705.0M	605.0M	707.0M	680.0M	339.0M	287.0M	274.0M	241.0M	232.0M	223.0M
Cash Paid For Goods	472.0M	572.0M	651.0M	530.0M	413.0M	440.0M	509.0M	493.0M	369.0M	395.0M	303.0M	463.0M	396.0M	148.0M	116.0M	92.5M	97.1M	99.0M	108.0M
Cash Paid To Employees	316.0M	298.0M	306.0M	274.0M	227.0M	244.0M	220.0M	180.0M	133.0M	106.0M	96.1M	91.1M	69.8M	48.9M	40.6M	36.4M	35.5M	32.1M	31.6M
Taxes Paid	157.0M	173.0M	133.0M	128.0M	132.0M	126.0M	134.0M	132.0M	117.0M	85.4M	53.6M	72.5M	45.4M	36.6M	33.9M	32.6M	45.6M	27.8M	21.8M
Total Operating Cash Outflow	1.1B	1.2B	1.3B	1.2B	998.0M	1.1B	1.0B	958.0M	770.0M	782.0M	560.0M	762.0M	603.0M	298.0M	246.0M	216.0M	224.0M	199.0M	200.0M
Operating Cash Flow	311.0M	291.0M	358.0M	306.0M	328.0M	285.0M	83.4M	75.9M	344.0M	-76.0M	45.7M	-54.9M	77.2M	41.4M	41.1M	57.8M	17.1M	33.9M	22.2M
Total Investing Cash Inflow	941.0M	443.0M	701.0M	413.0M	98.6M	20.7M	7.5M	208,700	3.3M	37.3M	21.0M	14.3M	41.1M	31.6M	233,400	--	--	13.3M	44,200
Total Investing Cash Outflow	1.0B	656.0M	593.0M	482.0M	222.0M	266.0M	166.0M	441.0M	317.0M	416.0M	44.8M	57.8M	253.0M	101.0M	35.9M	4.4M	2.4M	4.4M	3.0M
Investing Cash Flow	-106.0M	-212.0M	109.0M	-69.0M	-123.0M	-245.0M	-158.0M	-441.0M	-314.0M	-379.0M	-23.7M	-43.5M	-212.0M	-69.5M	-35.7M	-4.4M	-2.4M	8.8M	-2.9M
Cash From Borrowings	10.0M	20.9M	85.5M	70.1M	138.0M	431.0M	175.0M	311.0M	80.0M	191.0M	143.0M	135.0M	15.6M	--	--	60.0M	80.0M	75.0M	205.0M
Dividends And Interest Paid	96.5M	92.8M	77.3M	69.4M	23.4M	65.1M	57.4M	69.1M	40.4M	29.4M	14.2M	17.8M	13.3M	8.0M	8.0M	16.0M	2.9M	8.0M	8.9M
Debt Repayments	20.9M	21.0M	164.0M	157.0M	352.0M	335.0M	86.5M	41.0M	170.0M	201.0M	104.0M	77.8M	41.3M	--	25.0M	65.0M	90.0M	96.0M	220.0M
Total Financing Cash Inflow	10.7M	20.9M	88.8M	73.3M	455.0M	450.0M	176.0M	485.0M	84.0M	293.0M	827.0M	135.0M	18.6M	200,000	380.0M	60.0M	80.0M	75.0M	205.0M
Total Financing Cash Outflow	119.0M	115.0M	271.0M	249.0M	375.0M	400.0M	276.0M	111.0M	210.0M	231.0M	119.0M	95.6M	54.6M	8.0M	40.6M	81.0M	92.9M	104.0M	229.0M
Financing Cash Flow	-108.0M	-94.2M	-182.0M	-176.0M	79.8M	50.2M	-99.8M	373.0M	-126.0M	61.9M	708.0M	39.4M	-36.0M	-7.8M	339.0M	-21.0M	-12.9M	-29.1M	-23.9M
Net Change In Cash	99.3M	-13.2M	289.0M	59.3M	279.0M	90.4M	-173.0M	6.7M	-96.6M	-392.0M	730.0M	-59.3M	-171.0M	-35.8M	345.0M	32.4M	1.8M	13.0M	-5.1M
Ending Cash Balance	1.0B	914.0M	927.0M	638.0M	579.0M	300.0M	210.0M	383.0M	376.0M	473.0M	865.0M	135.0M	195.0M	366.0M	402.0M	57.1M	24.7M	22.9M	9.9M
Capex	30.9M	28.4M	61.6M	80.5M	118.0M	255.0M	160.0M	441.0M	245.0M	58.8M	28.8M	57.6M	190.0M	101.0M	35.9M	4.4M	2.4M	4.4M	3.0M